IGC Pharma, Inc. (IGC)
NYSEAMERICAN: IGC · Real-Time Price · USD
0.2800
0.00 (0.00%)
At close: Oct 7, 2026, 4:00 PM EDT
0.2800
0.00 (0.00%)
Pre-market: Oct 8, 2026, 4:00 AM EDT
IGC Pharma Market Cap
IGC Pharma has a market cap or net worth of $28.95 million as of October 7, 2026. That makes IGC Pharma the 34,458th most valuable company in the world and 5,044th in the United States. Its market cap has decreased by 21.34% in one year.
Market Cap
28.95M
Enterprise Value
27.96M
1-Year Change
-21.34%
Global Rank
Country Rank
#5,044 United States
Category
ChartMarket Cap Chart
Since May 24, 2006, IGC Pharma's market cap has decreased from $69.50M to $28.95M, a decrease of -58.35%. That is a compound annual growth rate of -4.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 28.95M | 11.34% |
| Dec 31, 2025 | 26.00M | - |
| Dec 31, 2024 | 26.00M | 46.07% |
| Dec 29, 2023 | 17.80M | 5.33% |
| Dec 30, 2022 | 16.90M | -66.13% |
| Dec 31, 2021 | 49.90M | -22.52% |
| Dec 31, 2020 | 64.40M | 158.63% |
| Dec 31, 2019 | 24.90M | -72.49% |
| Dec 31, 2018 | 90.50M | 222.06% |
| Dec 29, 2017 | 28.10M | 255.70% |
| Dec 30, 2016 | 7.90M | 102.56% |
| Dec 31, 2015 | 3.90M | -58.06% |
| Dec 31, 2014 | 9.30M | 19.23% |
| Dec 31, 2013 | 7.80M | -3.70% |
| Dec 31, 2012 | 8.10M | 32.79% |
| Dec 30, 2011 | 6.10M | -22.78% |
| Dec 31, 2010 | 7.90M | -53.80% |
| Dec 31, 2009 | 17.10M | 101.18% |
| Dec 31, 2008 | 8.50M | -89.66% |
| Dec 31, 2007 | 82.20M | 0.74% |
| Dec 29, 2006 | 81.60M | 17.41% |
| May 24, 2006 | 69.50M | - |
View and export this data all the way back to 2006. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immutep | 30.77M |
| NextCure | 30.03M |
| TransCode Therapeutics | 29.80M |
| GridAI Technologies | 29.17M |
| Context Therapeutics | 28.72M |
| Seres Therapeutics | 27.32M |
| aTyr Pharma | 27.30M |
| Quince Therapeutics | 27.18M |